Stay updated with breaking news from Drugs Controller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company has received licence and authorisation from DCGI to manufacture and market favipiravir oral suspension l00mg/ml, Bharat Parenterals said in a regulatory filing.
New Delhi [India], May 22 (ANI): With the national capital battling the third wave of the COVID-19 pandemic, Lieutenant Governor Anil Baijal on Saturday instructed the Delhi government authorities to ensure that drugs related to COVID treatment are made available to people to check hoarding, overcharging or black marketing of such medicines, dealers should display required stocks of such drugs.
Ensure availability of drugs for COVID treatment: Delhi LG ANI 22 May 2021, 22:19 GMT+10 New Delhi [India], May 22 (ANI): With the national capital battling the third wave of the COVID-19 pandemic, Lieutenant Governor Anil Baijal on Saturday instructed the Delhi government authorities to ensure that drugs related to COVID treatment are made available to people to check hoarding, overcharging or black marketing of such medicines, dealers should display required stocks of such drugs. "Hoarding, overcharging or black marketing of such medicines does not take place, by prominently displaying stoc...
The IMA has said that the Union health ministry should take action against Ramdev for making unlearned statements and defaming scientific medicine. NEW DELHI: Baba Ramdev has no ill-will against modern science or its practitioners, his firm Patanjali said on Saturday. This came in response to Indian Medical Association's (IMA) statement accusing Baba Ramdev of misleading people by making "unlearned" remarks against allopathy. Citing a video circulating on social media, the IMA said Ramdev has claimed that “allopathy is a stupid science" and medicines such as remdesivir, faviflu, and other...
NEW DELHI: Dr Reddy's on Wednesday said that the supply of anti-Covid drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO) is expected to commence in mid-June. In a statement, Hyderabad based Dr Reddy's said that the drug has not been launched in the market yet and people should be cautious of agents selling spurious or illegal products in the name of 2DG. The anti-Covid therapeutic application of the drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with...